Boceprevir-based Therapy to Rescue HCV Genotype 1/HBV Infected Patients Refractory to Combination Therapy

NCT02060058 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: Stop trial intervention for boceprevir, PEG-IFN and RBV

Sponsor

Kaohsiung Medical University Chung-Ho Memorial Hospital

Collaborators

[object Object]